# levothyroxine sodium

NDC: 47781-657
Generic name: levothyroxine sodium
Labeler / Manufacturer: Alvogen, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190507

FDA application: NDA021116

## Active ingredients

- LEVOTHYROXINE SODIUM: 125 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47781-657"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47781-657
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ddcaec1-a58f-340b-9bc1-bbe048b8c885